Actively Recruiting
Assessment of Personalized Follow-up in Prevention of Type 2 Diabetes
Led by Ramsay Générale de Santé · Updated on 2022-04-13
230
Participants Needed
1
Research Sites
314 weeks
Total Duration
On this page
Sponsors
R
Ramsay Générale de Santé
Lead Sponsor
E
European Clinical Trial Experts Network
Collaborating Sponsor
AI-Summary
What this Trial Is About
In France, the overall prevalence of diabetes was estimated at 5% of population in 2016, type 2 diabetes (T2DM) corresponding to 90% of cases. However, this figure is greatly underestimated,since it does not take into account people who are untreated or not diagnosed. However,it is estimated that 20 to 30% of adults with diabetes do not are not diagnosed. Conclusions presented during the annual meeting of the european Association for the Study of diabetes (EASD-Berlin) from 2019 suggest that signs precursors of the disease would be present up to 20 years before the diagnosis. The Diagnosis is usually made around 40-50 years. The main factor of risk of T2D is the lifestyle, in particular a diet too rich for a too sedentary daily life. From a medico-economic point of view, chronic pathologies (including diabetes) account for 60% of insurance expenditure illness even though they concern 35% of insured persons, i.e. 20 million patients. The average annual repayment of a type 2 diabetic patient is 4890 euros. This study is part of this context as the starting point a reflection on a different, coordinated management, to know a preventive rather than a curative approach.
CONDITIONS
Official Title
Assessment of Personalized Follow-up in Prevention of Type 2 Diabetes
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient, male or female, over the age of 18
- Patient with a FINDRISC score �3E�3D10 points
- Beneficiary of a French health insurance system
- Patient having been informed and having given their consent free, enlightened and written
You will not qualify if you...
- Patient over 75 years old
- Patient already diagnosed with type 2 diabetes
- Patient whose physical and/or psychological health is severely impaired, which according to the investigator may affect the compliance of the study participant
- Patient participating in another research
- Patient in period of exclusion from another research always in progress at the time of inclusion
- Protected patient: adult under guardianship, curatorship or other legal protection, deprived of liberty by court order or administration
- Pregnant, breastfeeding or parturient women
- Patient hospitalized without consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Clinique Aguiléra
Biarritz, Aquitaine, France, 64200
Actively Recruiting
Research Team
J
JF OUDET
CONTACT
M
MH BArba
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here